Evaluation in Vivo of Mouthwash With Nanoencapsulated Fluoride
Evaluation in Vivo of Experimental Mouthwash With Nanoencapsulated Fluoride
1 other identifier
interventional
21
1 country
1
Brief Summary
The literature recognizes that fluoride is the most widely used and studied means for dental remineralization. The use of fluoride mouthwashes is shown as an effective way to increase the fluoride intraoral availability. However, the current challenge is the substantivity, so new compounds have been introduced into these formulations. This study aims to evaluate the in vivo effect of fluoride mouthwash containing nanoencapsulated Fluoride (NanoF) - in fluoride retention in saliva and dental plaque. A study of the clinical and laboratory type, crossover, double-blind, randomized will be held. After sample calculation, the total of 12 individuals aged between 18 and 35 years old, healthy, decayed, missing, and filled teeth index less than 6 and residents in brazilian northeast capital will be part of the sample. Fluoride bioavailability will be evaluated in the biofilm and saliva after the use of fluoridated weekly. The biofilm will be assessed on 1h and 12 h after rinsing; and unstimulated saliva in times of 3, 15, 30, 45, 60 minutes and 12 hours after. It will be 3 mouthwashes: 50% Nanoencapsulated Fluoride, 100% Nanoencapsulated Fluoride and Free sodium fluoride. Between weeks of use, rinsing will be extended washout (without fluoride) to avoid carryover effect. Inferential data analysis will be carried out, considering the amount of alpha \<0.05. So knowing that caries is a dynamic process, the largest fluoride retention in the oral fluids promoted by the Nanoencapsulated Fluoride may have important impact on Des-Re process and in the control of dental caries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Nov 2016
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2017
CompletedFirst Submitted
Initial submission to the registry
November 18, 2021
CompletedFirst Posted
Study publicly available on registry
December 3, 2021
CompletedDecember 3, 2021
November 1, 2021
1 year
November 18, 2021
November 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bioavailability of intraoral fluoride (biofilm and saliva) collection of dental plaque(biofilm) and saliva
six months
Study Arms (4)
Placebo
PLACEBO COMPARATORMouthwash without fluoride.
Mouthwash standard
ACTIVE COMPARATORMouthwash with 225ppm sodium fluoride (NaF). Positive control.
Mouthwash 50% Nano-F
EXPERIMENTALMouthwash experimental with Fluoride being half of fluoride Nanoencapsulated and other half freeform of NaF.
Mouthwash 100% Nano-F
EXPERIMENTALMouthwash experimental with fluoride 100% Nanoencapsulated.
Interventions
Use 10 ml of mouthwash 100% Nanoencapsulated Fluoride after brushing for one week, twice a day.
Use 10 ml of mouthwash 50% Nanoencapsulated Fluoride after brushing for one week, twice a day.
Use 10 ml of mothwash after brushing for one week, twice a day. It's for the positive control of fluoride.
Eligibility Criteria
You may qualify if:
- resident in João Pessoa;
- Decayed, Missing, Filled Index\<6;
- Healthy
You may not qualify if:
- orthodontic treatment;
- gingivitis;
- Periodontal disease;
- Smokers;
- Present active tooth decay;
- Tooth sensitivity;
- Those undergoing treatment with fluoride products and / or use of antimicrobials in the past four weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal University of Paraíba
João Pessoa, Paraíba, Brazil
Related Publications (7)
Buzalaf MA, Vilhena FV, Iano FG, Grizzo L, Pessan JP, Sampaio FC, Oliveira RC. The effect of different fluoride concentrations and pH of dentifrices on plaque and nail fluoride levels in young children. Caries Res. 2009;43(2):142-6. doi: 10.1159/000211717. Epub 2009 Apr 8.
PMID: 19365118RESULTWhitford GM, Wasdin JL, Schafer TE, Adair SM. Plaque fluoride concentrations are dependent on plaque calcium concentrations. Caries Res. 2002 Jul-Aug;36(4):256-65. doi: 10.1159/000063931.
PMID: 12218274RESULTPessan JP, Silva SM, Lauris JR, Sampaio FC, Whitford GM, Buzalaf MA. Fluoride uptake by plaque from water and from dentifrice. J Dent Res. 2008 May;87(5):461-5. doi: 10.1177/154405910808700501.
PMID: 18434577RESULTPessan JP, Pinto Alves KM, Italiani Fde M, Ramires I, Lauris JR, Whitford GM, Toumba KJ, Robinson C, Buzalaf MA. Distribution of fluoride and calcium in plaque biofilms after the use of conventional and low-fluoride dentifrices. Int J Paediatr Dent. 2014 Jul;24(4):293-302. doi: 10.1111/ipd.12073.
PMID: 25045768RESULTPessan JP, Conceicao JM, Grizzo LT, Szekely M, Fazakas Z, Buzalaf MA. Intraoral fluoride levels after use of conventional and high-fluoride dentifrices. Clin Oral Investig. 2015 May;19(4):955-8. doi: 10.1007/s00784-015-1426-3. Epub 2015 Feb 14.
PMID: 25677244RESULTDuckworth RM, Jones S. On the relationship between the rate of salivary flow and salivary fluoride clearance. Caries Res. 2015;49(2):141-6. doi: 10.1159/000365949. Epub 2015 Jan 27.
PMID: 25634162RESULTDuckworth RM, Morgan SN, Gilbert RJ. Oral fluoride measurements for estimation of the anti-caries efficacy of fluoride treatments. J Dent Res. 1992 Apr;71 Spec No:836-40. doi: 10.1177/002203459207100S09.
PMID: 1592970RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Fábio Sampaio
University Federal of Paraiba
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 18, 2021
First Posted
December 3, 2021
Study Start
November 1, 2016
Primary Completion
November 15, 2017
Study Completion
December 20, 2017
Last Updated
December 3, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- January 2022 - January 2024
- Access Criteria
- free